logo
logo

Monogram Health Announces Series A-1 Funding to Further Kidney Health

May 05, 2020•about 5 years ago

Round Type

series a

BrentwoodBiotechnologyHealth CareMedical

Description

Monogram Health, a leading kidney disease care management company, announced today that it has secured $7 million in funding through the closing of a Series A-1 financing round. The round was co-led by Frist Cressey Ventures and Norwest Venture Partners. The funding represents another significant milestone for Monogram as the company continues to grow, increase health plan partnerships and manage the care of vulnerable patients with kidney disease through in-home engagement and increased interaction during this time of heightened isolation brought forth by the COVID-19 pandemic.

Company Information

Company

Monogram Health

Location

Brentwood, Tennessee, United States

About

Monogram Health is a leading value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with polychronic conditions. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, TPG Capital, Norwest Venture Partners, as well as other leading strategic and financial investors, Monogram Health has numerous value-based partnerships with leading health plans and risk-bearing providers to care for patients across 34 states and all insurance products.

Related People